Aycan and Enspectra partner for clinical trials on cellular imaging system

Radiology workflow and data management company Aycan Medical Systems has expanded into the clinical trials market. 

In a partnership with medical imaging diagnostics company Enspectra Health, Aycan provided imaging data management to support a pivotal clinical trial of Enspectra’s new VIO system. The first-of-its-kind technology visualizes, captures and stores images at the cellular level for more clinically accurate assessments of health. For now, VIO has received FDA clearance for use on skin after the successful proof-of-concept study.

According to a statement, the partnership between the two companies will be ongoing, with Enspectra utilizing Aycan cloud PACS and DICOM image archiving as it looks to conduct more trials to expand applications for VIO. 

Enspectra’s website states its cellular imaging capabilities will have a variety of clinical applications.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.